✦ LIBER ✦

Plasma and cerebrospinal fluid α1-antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment

✍ Scribed by Steven T. DeKosky; Milos D. Ikonomovic; Xiaoyan Wang; Martin Farlow; Stephen Wisniewski; Oscar L. Lopez; James T. Becker; Judith Saxton; William E. Klunk; Robert Sweet; Daniel I. Kaufer; M. Ilyas Kamboh

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 99 KB
Volume: 53
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.10414

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased levels of τ protein in cerebro

Increased levels of τ protein in cerebrospinal fluid of patients with alzheimer's disease—correlation with degree of cognitive impairment

✍ Christoph Hock; Sidonie Golombowski; Werner Naser; Franz MüLler-Spahn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Alzheimer's disease and hereditary cereb

Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis–dutch type share a decrease in cerebrospinal fluid levels of amyloid β-protein precursor

✍ Dr. William E. van Nostrand; Steven L. Wagner; Joost Haan; Egbert Bakker; Raymun 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

## Abstract The amyloid β‐protein is a 39‐42 amino acid peptide that is deposited in senile plaques and in cerebral vessel walls in individuals with Alzheimer's disease, Down's syndrome, hereditary cerebral hemorrhage with amyloidosis–Dutch type (HCHW A‐D), and, to a much lesser extent, normal agin

The selective muscarinic M1 agonist AF10

The selective muscarinic M1 agonist AF102B decreases levels of total Aβ in cerebrospinal fluid of patients with Alzheimer's disease

✍ Roger M. Nitsch; Meihua Deng; Marsha Tennis; David Schoenfeld; John H. Growdon 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB